Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.08 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Skip Burris III, M.D.

Member of Clinical Advisory Board, Poniard Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Howard A. Burris, Skip, III, MD serves as a Scientific and Clinical Advisor at ChemGenex Therapeutics, Inc. Dr. Burris serves as Chief Medical Officer and Director of Drug Development at The Sarah Cannon Cancer Center in Nashville, Tennessee, where he is also an Associate with Tennessee Oncology, PLLC. He served as Director of Clinical Research at the Institute for Drug Development and was an Associate Professor at the University of Texas Health Science Center. Dr. Burris ...

Read Full Background

Corporate Headquarters*

300 Elliott Avenue West
Seattle, Washington 98119

United States

Phone: 206-281-7001
Fax: 206-284-3181

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
University of South Alabama

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PARD:US $0.08 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PONIARD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.